# FDA Inspection 1015913 - Beth Israel Deaconess Medical Center IRB - May 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/5c8d76d5-8b76-45ba-b098-a48dffbebe86
Source feed: FDA_Inspections

> FDA Inspection 1015913 for Beth Israel Deaconess Medical Center IRB on May 25, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015913
- Company Name: Beth Israel Deaconess Medical Center IRB
- Inspection Date: 2017-05-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1240546 - 2024-05-08](https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/5e345e9a-e7eb-4be5-a847-f3b7fb5a870a)
- [FDA Inspection 1240546 - 2024-05-08](https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/324c5de3-7bd1-432e-bfba-79e6ede57050)
- [FDA Inspection 1240546 - 2024-05-08](https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/ac0974f6-0efe-43f1-bb87-9940e504c1fc)
- [FDA Inspection 799386 - 2012-09-20](https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/752264db-3280-481c-8c16-e90eafacecab)
- [FDA Inspection 614149 - 2009-09-24](https://www.keypedia.com/records/fda_inspections/beth-israel-deaconess-medical-center-irb/862f7e0d-d5ba-4cec-a9b8-e161edb1512b)

Company: https://www.keypedia.com/companies/beth-israel-deaconess-medical-center-irb/fb9ca884-7a9c-4d96-93a7-3928c6b06d0d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
